Independent Investment Research, "IIR", is an independent investment research house based in the USA and Australia.

News

Equity Research Coverage

IIR provides analyst coverage on companies providing fundamental analysis complete with a valuation.
Learn More

Company Profile Reporting

IIR provides company profile coverage on companies that do not qualify for valuation.

Learn More

Managed Investments

 Our research profiles includes managed investments both in the listed and unlisted sector and is published quarterly.

Equity Research
Company Profile Reporting
Managed Investments

What we do

IIR specialises in the analysis of high quality commissioned research for Brokers, Family Offices and Fund Managers. IIR distributes its research in Asia, United States and the Americas. IIR does not participate in any corporate or capital raising activity and therefore it does not have any inherent bias that may result from research that is linked to any corporate/ capital raising activity.
Learn More

Our Research

Equity Research Coverage

March 2, 2021

iCollege Limited (ASX: ICT) – Strong Domestiic Demand in Healthcare Training for COVID offsets Income not Generated from Overseas Students

ICT is an Vocational Education Training (VET) provider delivering accredited and non-accredited education and training solutions. In response to the economic impact stemming from the COVID-19 pandemic, the Federal, State and Territory Governments announced a number of stimulus packages for the VET sector - The company has directly benefited from these grants off setting any income that was expected from Overseas Students.
Register to Dowload
March 2, 2021

BNK Banking Corporation Limited (ASX: BBC) – Update – Aggregation Segment Continues to Drive Loan Book Growth

We have upgraded our price target from $1.12 to $1.19 per share. This represents a 63% premium to the share price of $0.73 at 22 February 2021. The upgrade is driven by two key factors: (1) Faster than expected growth in the Aggregation segment in 1H’FY21 has offset a reduction in forecast net interest income due to a reduction in forecast settlements in the Wholesale segment and declining interest rates, and.....
Register to Dowload
March 2, 2021

IIR Pharma & Biotech Index

We thought we’d kick off the year by taking a look at the top performing companies in the index for 2020. The top 10 performers are tabled below. There were some impressive returns for some of the companies in the index with 29 companies share prices rising by 100% or more.
Register to Dowload

Company Profile Reporting

February 11, 2020

Hexagon Energy Materials Limited (ASX: HXG) – Advancing REE Downstream Processing, Looking to Commercialise new Technology with the Potential to Disrupt the Chinese Domination

Our view is that Hexagon represents an excellent ‘ground-floor’ opportunity for investors to gain exposure to REE through a lower-risk, more commercially advanced business strategy than a typical upstream REE exploration/development play. The initial commercialisation strategy, targeting licencing the technology, will require relatively limited capital (and thus result in less dilution for shareholders), and will be located in North America
Register to Dowload
Listed / unlisted

Managed Investments

March 2, 2021

LMI Monthly – February 2021 – IIR LIC/LIT/ETF Research Scheme

Data Collected on a Monthly basis by the IIR Research team on the whole sector. ratings are applied to those Managers who participate in LIC/LIT/ETF Research Scheme and ratings are applied to those managers who participate in the IIR LIC/LIT/ETF Research and these ratings are subject to continuous coverage on a monthly basis.
Register to Dowload